SCHEMBL33378035

SCHEMBL33378035

CC(C)c1cnn2c(Nc3cccnn3)cc(Cl)nc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK2 P24941 12/20 0.40
▸ CDK7 P50613 11/20 0.40
▸ CCNE1 P24864 4/20 0.38
▸ CCNH P51946 4/20 0.38
▸ CDK1 P06493 3/20 0.38
▸ MNAT1 P51948 3/20 0.38
▸ GSK3B P49841 3/20 0.38
▸ CDK9 P50750 3/20 0.38
▸ CCNT1 O60563 2/20 0.38
▸ CDK4 P11802 2/20 0.38
▸ CCNB1 P14635 2/20 0.38
▸ CCND1 P24385 2/20 0.38
▸ CDK8 P49336 2/20 0.38
▸ CDK6 Q00534 2/20 0.38
▸ CDK5 Q00535 2/20 0.38
▸ CDK5R1 Q15078 1/20 0.38
▸ INSRR P14616 1/20 0.37
▸ MAPK3 P27361 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ CSNK1A1 P48729 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL33377988 0.85 CDK2 (0.42) CDK2CDK7CCNE1CCNHCDK1
SCHEMBL33377928 0.84 CDK7 (0.56) CDK2CDK7CCNE1CCNHCDK1
SCHEMBL33378016 0.82 CDK7 (0.46) CDK2CDK7CCNE1CCNHCDK1
SCHEMBL33378043 0.81 CDK7 (0.46) CDK2CDK7CCNE1CCNHCDK1
SCHEMBL33378029 0.81 CDK2 (0.41) CDK2CDK7CCNE1CCNHCDK1
SCHEMBL33377976 0.81 CDK2 (0.42) CDK2CDK7CCNE1CCNHCDK1
SCHEMBL33377933 0.80 GRM5 (0.43) CDK2CDK7CCNE1CCNHCDK1
SCHEMBL33377934 0.80 CDK2 (0.43) CDK2CDK7CCNE1CCNHCDK1
SCHEMBL33377883 0.79 CDK2 (0.43) CDK2CDK7CCNE1CCNHCDK1
SCHEMBL33378006 0.79 CDK2 (0.36) CDK2GSK3BDOT1L

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4717312-A1 PYRAZOLO[1,5-A]PYRIMIDINE DERIVATIVES USEFUL AS A MEDICAMENT Perha Pharmaceuticals (FR) 2026-04-01 — — EP disclosed
Send feedback